Karihtala, Peeter. “How to Choose Optimal Adjuvant Therapies for High-Risk Hormone Receptor-Positive, HER2-Negative Breast Cancer After Chemotherapy?”. Acta Oncologica 64 (June 25, 2025): 815–829. Accessed May 11, 2026. https://medicaljournalssweden.se/actaoncologica/article/view/43645.